{"id":"https://openalex.org/W29240568","doi":null,"title":"Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.","display_name":"Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.","publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W29240568","mag":"29240568","pmid":"https://pubmed.ncbi.nlm.nih.gov/2371368"},"language":"en","primary_location":{"id":"pmid:2371368","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2371368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057648973","display_name":"Jan Volavka","orcid":"https://orcid.org/0000-0002-4178-8207","observed_orcids":["https://orcid.org/0000-0002-4178-8207"]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Volavka","raw_affiliation_strings":["Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962","institution_ids":["https://openalex.org/I125043107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030014983","display_name":"Thomas B. Cooper","orcid":"https://orcid.org/0000-0001-6048-3479","observed_orcids":["https://orcid.org/0000-0001-6048-3479"]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T B Cooper","raw_affiliation_strings":["Nathan S Kline Institute for Psychiatric Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nathan S Kline Institute for Psychiatric Research","institution_ids":["https://openalex.org/I125043107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048528911","display_name":"Morris Meisner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Meisner","raw_affiliation_strings":["Nathan S Kline Institute for Psychiatric Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nathan S Kline Institute for Psychiatric Research","institution_ids":["https://openalex.org/I125043107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024434180","display_name":"Istv\u00e1n Bitter","orcid":"https://orcid.org/0000-0002-9464-4709","observed_orcids":["https://orcid.org/0000-0002-9464-4709"]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"I Bitter","raw_affiliation_strings":["Semmelweis University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Semmelweis University","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062114165","display_name":"P\u00e1l Czobor","orcid":"https://orcid.org/0000-0002-6361-8006","observed_orcids":["https://orcid.org/0000-0002-6361-8006"]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"P Czobor","raw_affiliation_strings":["Semmelweis University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Semmelweis University","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006572593","display_name":"Judith Jaeger","orcid":"https://orcid.org/0000-0002-3396-5402","observed_orcids":["https://orcid.org/0000-0002-3396-5402"]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Jaeger","raw_affiliation_strings":["Nathan S Kline Institute for Psychiatric Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nathan S Kline Institute for Psychiatric Research","institution_ids":["https://openalex.org/I125043107"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8601,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.83259912,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"26","issue":"1","first_page":"13","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":1.0},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.8989999890327454},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.8100000023841858},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-dose","display_name":"antipsychotic dosing","score":0.8270000219345093},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.6729999780654907},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6430000066757202},{"id":"https://openalex.org/keywords/brief-psychiatric-rating-scale","display_name":"Brief Psychiatric Rating Scale","score":0.8930000066757202}],"concepts":[{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.9769288897514343},{"id":"https://openalex.org/C2778528637","wikidata":"https://www.wikidata.org/wiki/Q4967025","display_name":"Brief Psychiatric Rating Scale","level":3,"score":0.8337295055389404},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.7990697622299194},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6530914902687073},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5244800448417664},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.5018315315246582},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.47533392906188965},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4442431330680847},{"id":"https://openalex.org/C3017575891","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma levels","level":2,"score":0.4308268129825592},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41357845067977905},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.39726686477661133},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.09460380673408508},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2371368","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2371368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Clinical Trial"},{"id":"mag:29240568","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2371368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G5030661978","display_name":"HALOPERIDOL BLOOD LEVELS AND EFFECTS IN SCHIZOPHRENIA","funder_award_id":"R01MH041772","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2115084880","https://openalex.org/W1980238542","https://openalex.org/W2123242720","https://openalex.org/W2100204732","https://openalex.org/W2075818860","https://openalex.org/W1993548319","https://openalex.org/W115808356","https://openalex.org/W2208892852","https://openalex.org/W1967370472","https://openalex.org/W2336635409"],"abstract_inverted_index":{"To":[0],"test":[1],"the":[2,49,68,98,113],"hypothesis":[3],"of":[4,20,24,40,48,67,91],"a":[5],"\"therapeutic":[6],"window,\"":[7],"we":[8],"have":[9,105],"randomly":[10,44],"assigned":[11,45],"acutely":[12],"exacerbating":[13],"schizophrenic":[14],"or":[15,29],"schizoaffective":[16],"patients":[17,81],"to":[18,46,104],"one":[19,47],"three":[21,50],"plasma":[22,89,101],"levels":[23,52],"haloperidol":[25,51,92,100,114],"(HAL):":[26],"2-13,":[27],"13.1-24,":[28],"24.1-35":[30],"ng/ml.":[31],"Patients":[32,96],"who":[33],"did":[34],"not":[35,83],"improve":[36],"after":[37],"6":[38,55],"weeks":[39],"this":[41],"treatment":[42],"were":[43],"for":[53],"another":[54],"weeks.":[56],"The":[57,76],"improvement":[58],"was":[59],"defined":[60],"as":[61],"at":[62],"least":[63],"50":[64],"percent":[65],"reduction":[66],"Brief":[69],"Psychiatric":[70],"Rating":[71],"Scale":[72],"(BPRS)":[73],"total":[74],"score.":[75],"results":[77,110],"obtained":[78],"in":[79,97,117],"111":[80],"do":[82],"support":[84],"any":[85],"consistent":[86],"relationship":[87],"between":[88],"level":[90],"and":[93],"clinical":[94,118],"improvement.":[95],"high":[99],"range":[102],"tended":[103],"more":[106],"side":[107],"effects.":[108],"These":[109],"suggest":[111],"that":[112],"doses":[115],"used":[116],"practice":[119],"may":[120],"be":[121],"higher":[122],"than":[123],"necessary.":[124]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
